Collagen synthesis in atherosclerosis: Too much and not enough

Cardiovascular Research

Volumn 41, Issue 2, 1999, Pages 376-384

  Rekhter, Mark D ^a  

^a PFIZER INC   (United States)

Author keywords

Atheroscterosis; Collagen; Gene expression; Plaque rupture; Restenosis

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; COLLAGEN; DEXTRAN; HALOFUGINONE; MIMOSINE; NITRIC OXIDE DONOR; PROTAMINE; TRANILAST;

ANGIOPLASTY; ANIMAL MODEL; ARTERY OCCLUSION; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CELL MIGRATION; CELL PROLIFERATION; CELL TYPE; COLLAGEN DEGRADATION; COLLAGEN SYNTHESIS; CORONARY ARTERY THROMBOSIS; GENE EXPRESSION; MACROPHAGE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RESTENOSIS; REVIEW; THROMBOGENESIS; TIME;

ARTERIES; ARTERIOSCLEROSIS; COLLAGEN; ENDOTHELIUM, VASCULAR; HOMOCYSTEINE; HUMANS; MUSCLE, SMOOTH, VASCULAR;

EID: 0032980074     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(98)00321-6     Document Type: Review

References (118)

1. Wight TN. The vascular extracellular matrix. In: Fuster V, Ross R, Topol EJ, editors. Atherosclerosis and coronary artery disease. Philadelphia: Lippincott-Raven, 1996:421-440.
2. Prockop D.J., Kivirikko K.I. Collagens: molecular biology, diseases, and potentials for therapy. Annu Rev Biochem. 64:1995;403-434.
3. Shekhonin B.V., Domogatsky S.P., Idelson G.L., Koteliansky V.E., Rukosuev V.S. Relative distribution of fibronectin and type I, III, IV, V collagens in normal and atherosclerotic intima of human arteries. Atherosclerosis. 67:1987;9-16.
4. Murata K., Motayama T., Kotake C. Collagen types in various layers of the human aorta and their changes with the atherosclerotic process. Atherosclerosis. 60:1986;251-262.
5. Ooshima A., Muragaki Y. Collagen metabolism in atherogenesis. Ann NY Acad Sci. 598:1990;582-584.
6. Katsuda S., Okada Y., Minamoto T., Oda Y., Matsui Y., Nakanishi I. Collagens in human atherosclerosis. Immunohistochemical analysis using collagen type-specific antibodies. Arterioscler Thromb. 12:1992;494-502.
7. Ross R., Wight T.N., Strandness E., Thiele B. Human atherosclerosis. I. Cell constitution and characteristics of advanced lesions of the superficial femoral artery. Am J Pathol. 114:1984;79-93.
8. Smith E.B. The influence of age and atherosclerosis on the chemistry of aortic intima. J Atheroscler Res. 5:1965;241-248.
9. Greilberger J., Schmut O., Jurgens G. In vitro interactions of oxidatively modified LDL with type I, II, III, IV, and V collagen, laminin, fibronectin, and poly-D-lysine. Arterioscler Thromb Vasc Biol. 17:1997;2721-2728.
10. Taipale J., Keski Oja J. Growth factors in the extracellular matrix. FASEB J. 11:1997;51-59.
11. Vlassara H. Advanced glycation end-products and atherosclerosis. Ann Med. 28:1998;419-426.
12. Wesley R.B., Meng X., Godin D., Galis Z.S. Extracellular matrix modulates macrophage functions characteristic to atheroma: collagen type I enhances acquisition of resident macrophage traits by human peripheral blood monocytes in vitro. Arterioscler Thromb Vasc Biol. 18:1998;432-440.
13. Koyama H., Raines E.W., Bornfeldt K.E., Roberts J.M., Ross R. Fibrillar collagen inhibits arterial smooth muscle proliferation through regulation of Cdk2 inhibitors. Cell. 87:1996;1069-1078.
14. Rocnik E.F., Chan B.M., Pickering J.G. Evidence for a role of collagen synthesis in arterial smooth muscle cell migration. J Clin Invest. 101:1998;1889-1898.
15. Zheng B., Duan C., Clemmons D.R. The effect of extracellular matrix proteins on porcine smooth muscle cell insulin-like growth factor (IGF) binding protein-5 synthesis and responsiveness to IGF-I. J Biol Chem. 273:1998;8994-9000.
16. Roald H.E., Lyberg T., Dedichen H.et al. Collagen-induced thrombus formation in flowing nonanticoagulated human blood from habitual smokers and nonsmoking patients with severe peripheral atherosclerotic disease. Arterioscler Thromb Vasc Biol. 15:1995;128-132.
17. Lee R.T., Libby P. The unstable atheroma. Arterioscler Thromb Vasc Biol. 17:1997;1859-1867.
18. Burleigh M.C., Briggs A.D., Lendon C.L., Davies M.J., Born G.V., Richardson P.D. Collagen types I and III, collagen content, GAGs and mechanical strength of human atherosclerotic plaque caps: span-wise variations. Atherosclerosis. 96:1992;71-81.
19. Fuster V. Elucidation of the role of plaque instability and rupture in acute coronary events. Am J Cardiol. 76:1995;24C-33C.
20. Slack J.L., Liska D.J., Bornstein P. Regulation of expression of the type I collagen genes. Am J Med Genet. 45:1993;140-151.
21. Karsenty G., Park R.W. Regulation of type I collagen genes expression. Int Rev Immunol. 12:1995;177-185.
22. Brenner D.A., Rippe R.A., Rhodes K., Trotter J.F., Breindl M. Fibrogenesis and type I collagen gene regulation. J Lab Clin Med. 124:1994;755-760.
23. Trojanowska M., LeRoy E.C., Eckes B., Krieg T. Pathogenesis of fibrosis: type 1 collagen and the skin. J Mol Med. 76:1998;266-274.
24. Rekhter M.D., Zhang K., Narayanan A.S., Phan S., Schork M.A., Gordon D. Type I collagen gene expression in human atherosclerosis. Localization to specific plaque regions. Am J Pathol. 143:1993;1634-1648.
25. Jaeger E., Rust S., Roessner A.et al. Joint occurrence of collagen mRNA containing cells and macrophages in human atherosclerotic vessels. Atherosclerosis. 86:1991;55-68.
26. Kivirikko K.I. Collagen biosynthesis: a mini-review cluster. Matrix Biol. 16:1998;355-356.
27. Burgeson R.E., Nimni M.E. Collagen types. Molecular structure and tissue distribution. Clin Orthop. 282:1992;250-272.
28. Canfield A.E., Wren F.E., Schor S.L., Grant M.E., Schor A.M. Aortic endothelial cell heterogeneity in vitro. Lack of association between morphological phenotype and collagen biosynthesis. J Cell Sci. 102:1992;807-814.
29. Tintut Y., Parhami F., Bostrom K., Jackson S.M., Demer L.L. cAMP stimulates osteoblast-like differentiation of calcifying vascular cells. Potential signaling pathway for vascular calcification. J Biol Chem. 273:1998;7547-7553.
30. Rekhter M.D., O'Brien E., Shah N., Schwartz S.M., Simpson J.B., Gordon D. The importance of thrombus organization and stellate cell phenotype in collagen I gene expression in human, coronary atherosclerotic and restenotic lesions. Cardiovasc Res. 32:1996;496-502.
31. Andreeva E.R., Pugach I.M., Orekhov A.N. Collagen-synthesizing cells in initial and advanced atherosclerotic lesions of human aorta. Atherosclerosis. 130:1997;133-142.
32. Thyberg J. Differentiated properties and proliferation of arterial smooth muscle cells in culture. Int Rev Cytol. 169:1996;183-265.
33. Sjolund M., Madsen K., von-der-Mark K., Thyberg J. Phenotype modulation in primary cultures of smooth-muscle cells from rat aorta. Synthesis of collagen and elastin. Differentiation. 32:1986;173-180.
34. Ang A.H., Tachas G., Campbell J.H., Bateman J.F., Campbell G.R. Collagen synthesis by cultured rabbit aortic smooth-muscle cells. Alteration with phenotype. Biochem J. 265:1990;461-469.
35. Okada Y., Katsuda S., Matsui Y., Watanabe H., Nakanishi I. Collagen synthesis by cultured arterial smooth muscle cells during spontaneous phenotypic modulation. Acta Pathol Jpn. 40:1990;157-164.
36. Majors A.K., Ehrhart L.A. Cell density and proliferation modulate collagen synthesis and procollagen mRNA levels in arterial smooth muscle cells. Exp Cell Res. 200:1992;168-174.
37. Holderbaum D., Ehrhart L.A. Modulation of types I and III procollagen synthesis at various stages of arterial smooth muscle cell growth in vitro. Exp Cell Res. 153:1984;16-24.
38. Kindy M.S., Chang C.J., Sonenshein G.E. Serum deprivation of vascular smooth muscle cells enhances collagen gene expression. J Biol Chem. 263:1988;11426-11430.
39. Liau G., Chan L.M. Regulation of extracellular matrix RNA levels in cultured smooth muscle cells. Relationship to cellular quiescence. J Biol Chem. 264:1989;10315-10320.
40. Marhamati D.J., Sonenshein G.E. B-Myb expression in vascular smooth muscle cells occurs in a cell cycle-dependent fashion and down-regulates promoter activity of type I collagen genes. J Biol Chem. 271:1996;3359-3365.
41. Rekhter M.D., Gordon D. Cell proliferation and collagen synthesis are two independent events in human atherosclerotic plaques. J Vasc Res. 31:1994;280-286.
42. Amento E.P., Ehsani N., Palmer H., Libby P. Cytokines and growth factors positively and negatively regulate interstitial collagen gene expression in human vascular smooth muscle cells. Arterioscler Thromb. 11:1991;1223-1230.
43. Schlumberger W., Thie M., Rauterberg J., Robenek H. Collagen synthesis in cultured aortic smooth muscle cells. Modulation by collagen lattice culture, transforming growth factor-beta 1, and epidermal growth factor. Arterioscler Thromb. 11:1991;1660-1666.
44. Davidson J.M., Zoia O., Liu J.M. Modulation of transforming growth factor-beta 1 stimulated elastin and collagen production and proliferation in porcine vascular smooth muscle cells and skin fibroblasts by basic fibroblast growth factor, transforming growth factor-alpha, and insulin-like growth factor-I. J Cell Physiol. 155:1993;149-156.
45. Majesky M.W., Lindner V., Twardzik D.R., Schwartz S.M., Reidy M.A. Production of transforming growth factor beta 1 during repair of arterial injury. J Clin Invest. 88:1991;904-910.
46. Nabel E.G., Shum L., Pompili V.J.et al. Direct transfer of transforming growth factor beta 1 gene into arteries stimulates fibrocellular hyperplasia. Proc Natl Acad Sci USA. 90:1993;10759-10763.
47. Oemar B.S., Luscher T.F. Connective tissue growth factor. Friend or foe? Arterioscler Thromb Vasc Biol. 17:1997;1483-1489.
48. McCaffrey T.A., Consigli S., Du B.et al. Decreased type II/type I TGF-β receptor ratio in cells derived from human atherosclerotic lesions. Conversion from an antiproliferative to profibrotic response to TGF-β1. J Clin Invest. 96:1995;2667-2675.
49. McCaffrey T.A., Du B., Consigli S.et al. Genomic instability in the type II TGF-β1 receptor gene in atherosclerotic and restenotic vascular cells. J Clin Invest. 100:1997;2182-2188.
50. Pompili V.J., Gordon D., San H.et al. Expression and function of a recombinant PDGF B gene in porcine arteries. Arterioscler Thromb Vasc Biol. 15:1995;2254-2264.
51. Okada Y., Katsuda S., Watanabe H., Nakanishi I. Collagen synthesis of human arterial smooth muscle cells: effects of platelet-derived growth factor, transforming growth factor-β1 and interleukin-1. Acta Pathol Jpn. 43:1993;160-167.
52. Rizvi M.A., Katwa L., Spadone D.P., Myers P.R. The effects of endothelin-1 on collagen type I and type III synthesis in cultured porcine coronary artery vascular smooth muscle cells. J Mol Cell Cardiol. 28:1996;243-252.
53. Kato H., Suzuki H., Tajima S.et al. Angiotensin II stimulates collagen synthesis in cultured vascular smooth muscle cells. J Hypertens. 9:1991;17-22.
54. Pickering J.G., Ford C.M., Tang B., Chow L.H. Coordinated effects of fibroblast growth factor-2 on expression of fibrillar collagens, matrix metalloproteinases, and tissue inhibitors of matrix metalloproteinases by human vascular smooth muscle cells. Evidence for repressed collagen production and activated degradative capacity. Arterioscler Thromb Vasc Biol. 17:1997;475-482.
55. Kypreos K.E., Sonenshein G.E. Basic fibroblast growth factor decreases type V/XI collagen expression in cultured bovine aortic smooth muscle cells. J Cell Biochem. 68:1998;247-258.
56. Majors A., Ehrhart L.A. Basic fibroblast growth factor in the extracellular matrix suppresses collagen synthesis and type III procollagen mRNA levels in arterial smooth muscle cell cultures. Arterioscler Thromb. 13:1993;680-686.
57. Kato S., Muraishi A., Miyamoto T., Fox J.C. Basic fibroblast growth factor regulates extracellular matrix and contractile protein expression independent of proliferation in vascular smooth muscle cells. In Vitro Cell Dev Biol Anim. 34:1998;341-346.
58. Kolpakov V., Gordon D., Kulik T.J. Nitric oxide-generating compounds inhibit total protein and collagen synthesis in cultured vascular smooth muscle cells. Circ Res. 76:1995;305-309.
59. Myers P.R., Tanner M.A. Vascular endothelial cell regulation of extracellular matrix collagen: role of nitric oxide. Arterioscler Thromb Vasc Biol. 18:1998;717-722.
60. Gupta S., Pablo A.M., Jiang X., Wang N., Tall A.R., Schindler C. IFN-γ potentiates atherosclerosis in ApoE knock-out mice. J Clin Invest. 99:1997;2752-2761.
61. Hansson G.K., Holm J. Interferon-γ inhibits arterial stenosis after injury. Circulation. 84:1991;1266-1272.
62. Hansson G.K., Holm J., Holm S., Fotev Z., Hedrich H.J., Fingerle J. T lymphocytes inhibit the vascular response to injury. Proc Natl Acad Sci USA. 88:1991;10530-10534.
63. Holderbaum D., Ehrhart L.A. Substratum influence on collagen and fibronectin biosynthesis by arterial smooth muscle cells in vitro. J Cell Physiol. 126:1986;216-224.
64. Thie M., Schlumberger W., Semich R., Rauterberg J., Robenek H. Aortic smooth muscle cells in collagen lattice culture: effects on ultrastructure, proliferation and collagen synthesis. Eur J Cell Biol. 55:1991;295-304.
65. Redecker B.B., Thie M., Rauterberg J., Robenek H. Aortic smooth muscle cells in a three-dimensional collagen lattice culture. Evidence for posttranslational regulation of collagen synthesis. Arterioscler Thromb. 13:1993;1572-1579.
66. Kollros P.R., Bates S.R., Mathews M.B., Horwitz A.L., Glagov S. Cyclic AMP inhibits increased collagen production by cyclically stretched smooth muscle cells. Lab Invest. 56:1987;410-417.
67. Kulik T.J., Alvarado S.P. Effect of stretch on growth and collagen synthesis in cultured rat and lamb pulmonary arterial smooth muscle cells. J Cell Physiol. 157:1993;615-624.
68. Sumpio B.E., Banes A.J., Link W.G., Johnson G. Enhanced collagen production by smooth muscle cells during repetitive mechanical stretching. Arch Surg. 123:1988;1233-1236.
69. Hume W.R. Proline and thymidine uptake in rabbit ear artery segments in vitro increased by chronic tangential load. Hypertension. 2:1980;738-743.
70. Kolpakov V., Rekhter M.D., Gordon D., Wang W.H., Kulik T.J. Effect of mechanical forces on growth and matrix protein synthesis in the in vitro pulmonary artery. Analysis of the role of individual cell types. Circ Res. 77:1995;823-831.
71. Li Q., Muragaki Y., Hatamura I., Ueno H., Ooshima A. Stretch-induced collagen synthesis in cultured smooth muscle cells from rabbit aortic media and a possible involvement of angiotensin II and transforming growth factor-β J Vasc Res. 35:1998;93-103.
72. Ross R. The pathogenesis of atherosclerosis. In: Braunwald E, editor. Heart disease: a textbook of cardiovascular medicine, 5th edn. Philadelphia: WB Saunders, 1997:1105-1125.
73. Libby P., Schoenbeck U., Mach F., Selwyn A.P., Ganz P. Current concepts in cardiovascular pathology: the role of LDL cholesterol in plaque rupture and stabilization. Am J Med. 104:1998;14S-18S.
74. Jimi S., Saku K., Uesugi N., Sakata N., Takebayashi S. Oxidized low density lipoprotein stimulates collagen production in cultured arterial smooth muscle cells. Atherosclerosis. 116:1995;15-26.
75. Jimi S., Sakata N., Takebayashi S. Oxidized LDL induces an increase in the relative collagen synthesis of rabbit aortic smooth muscle cells. J Atheroscler Thromb. 1:1994;53-59.
76. Orekhov A.N., Tertov V.V., Kudryashov S.A., Smirnov V.N. Triggerlike stimulation of cholesterol accumulation and DNA and extracellular matrix synthesis induced by atherogenic serum or low density lipoprotein in cultured cells. Circ Res. 66:1990;311-320.
77. Jarvelainen H., Halme T., Lehtonen A., Ronnemaa T. Serum from type IIA hyperlipoproteinemic patients does not stimulate proliferation of and collagen synthesis in human fetal aortic smooth muscle cells in culture. Atherosclerosis. 56:1985;199-211.
78. Holderbaum D., Ehrhart L.A. Inhibition of collagen and non-collagen protein synthesis in cultured aortic smooth muscle cells by hyperlipoproteinemic serum. Artery. 7:1980;16-31.
79. St.-Clair R.W., Jones D.C., Hester S.H. Failure of hypercholesterolemic serum to stimulate collagen synthesis in aortic smooth muscle cells from two species of nonhuman primates having different rates of collagen synthesis. Proc Soc Exp Biol Med. 174:1983;137-142.
80. Welch G.N., Loscalzo J. Homocysteine and atherothrombosis. New Engl J Med. 338:1998;1042-1050.
81. Majors A., Ehrhart L.A., Pezacka E.H. Homocysteine as a risk factor for vascular disease. Enhanced collagen production and accumulation by smooth muscle cells. Arterioscler Thromb Vasc Biol. 17:1997;2074-2081.
82. Fischer G.M., Cherian K., Swain M.L. Increased synthesis of aortic collagen and elastin in experimental atherosclerosis. Inhibition by contraceptive steroids. Atherosclerosis. 39:1981;463-467.
83. Fischer G.M., Swain M.L. Effects of estradiol and progesterone on the increased synthesis of collagen in atherosclerotic rabbit aortas. Atherosclerosis. 54:1985;177-185.
84. Botney M.D., Kaiser L.R., Cooper J.D.et al. Extracellular matrix protein gene expression in atherosclerotic hypertensive pulmonary arteries. Am J Pathol. 140:1992;357-364.
85. Nikkari S.T., Geary R.L., Hatsukami T.et al. Expression of collagen, interstitial collagenase, and tissue inhibitor of metalloproteinases-1 in restenosis after carotid endarterectomy. Am J Pathol. 148:1996;777-783.
86. Langner R.O., Modrak J.B. Alteration of collagen synthesis in different tissues of the atherosclerotic rabbit. Artery. 9:1981;253-261.
87. Fischer G.M., Swain M.L., Cherian K. Increased vascular collagen and elastin synthesis in experimental atherosclerosis in the rabbit. Variation in synthesis among major vessels. Atherosclerosis. 35:1980;11-20.
88. Opsahl W.P., DeLuca D.J., Ehrhart L.A. Accelerated rates of collagen synthesis in atherosclerotic arteries quantified in vivo. Arteriosclerosis. 7:1987;470-476.
89. Ehrhart L.A., Holderbaum D. Stimulation of aortic protein synthesis in experimental rabbit atherosclerosis. Atherosclerosis. 27:1977;477-485.
90. Clowes A.W., Reidy M.A., Clowes M.M. Mechanisms of stenosis after arterial injury. Lab Invest. 49:1983;208-215.
91. Nikkari S.T., Jarvelainen H.T., Wight T.N., Ferguson M., Clowes A.W. Smooth muscle cell expression of extracellular matrix genes after arterial injury. Am J Pathol. 144:1994;1348-1356.
92. Wang H., Li Z., Moore S., Alavi M.Z. Collagen biosynthesis by neointimal smooth muscle cells cultured from rabbit aortic explants 15 weeks after de-endothelialization. Int J Exp Pathol. 79:1998;47-53.
93. Liptay M.J., Parks W.C., Mecham R.P.et al. Neointimal macrophages colocalize with extracellular matrix gene expression in human atherosclerotic pulmonary arteries. J Clin Invest. 91:1993;588-594.
94. Bahadori L., Milder J., Gold L., Botney M. Active macrophage-associated TGF-β co-localizes with type I procollagen gene expression in atherosclerotic human pulmonary arteries. Am J Pathol. 146:1995;1140-1149.
95. Jaeger E., Rust S., Scharffetter K.et al. Localization of cytoplasmic collagen mRNA in human aortic coarctation: mRNA enhancement in high blood pressure-induced intimal and medial thickening. J Histochem Cytochem. 38:1990;1365-1375.
96. Jackson C.J., Jenkins K.L. Type I collagen fibrils promote rapid vascular tube formation upon contact with the apical side of cultured endothelium. Exp Cell Res. 192:1991;319-323.
97. Vernon R.B., Lara S.L., Drake C.J.et al. Organized type I collagen influences endothelial patterns during "spontaneous angiogenesis in vitro": planar cultures as models of vascular development. In Vitro Cell Dev Biol Anim. 31:1995;120-131.
98. Stemme S., Hansson G.K. Immune mechanisms in atherosclerosis. Coron Artery Dis. 5:1994;216-222.
99. Schwartz S.M., Bennett M.R. Death by any other name [comment]. Am J Pathol. 147:1995;229-234.
100. Rekhter M.D., Hicks G.W., Brammer D.W.et al. Animal model that mimics atherosclerotic plaque rupture. Circ Res. 83:1998;705-713.
101. Pickering J.G., Ford C.M., Chow L.H. Evidence for rapid accumulation and persistently disordered architecture of fibrillar collagen in human coronary restenosis lesions. Am J Cardiol. 78:1996;633-637.
102. Koyama H., Reidy M.A. Expression of extracellular matrix proteins accompanies lesion growth in a model of intimal reinjury. Circ Res. 82:1998;988-995.
103. Strauss B.H., Chisholm R.J., Keeley F.W., Gotlieb A.I., Logan R.A., Armstrong P.W. Extracellular matrix remodeling after balloon angioplasty injury in a rabbit model of restenosis. Circ Res. 75:1994;650-658.
104. Strauss B.H., Robinson R., Batchelor W.B.et al. In vivo collagen turnover following experimental balloon angioplasty injury and the role of matrix metalloproteinases. Circ Res. 79:1996;541-550.
105. Coats W.D. Jr., Whittaker P, Cheung D.T., Currier J.W., Han B., Faxon D.P. Collagen content is significantly lower in restenotic versus nonrestenotic vessels after balloon angioplasty in the atherosclerotic rabbit model. Circulation. 95:1997;1293-1300.
106. Geary R.L., Nikkari S.T., Wagner W.D., Williams J.K., Adams M.R., Dean R.H. Wound healing: a paradigm for lumen narrowing after arterial reconstruction. J Vasc Surg. 27:1998;96-106.
107. 2+ channel blockers modulate metabolism of collagens within the extracellular matrix. Proc Natl Acad Sci USA. 93:1996;5478-5482.
108. Benazzoug Y., Logeart D., Labat R.J., Robert L., Jozefonvicz J., Kern P. Derivatized dextrans modulate collagen synthesis in aortic smooth muscle cells. Biochem Pharmacol. 49:1995;847-853.
109. Fukuyama J., Miyazawa K., Hamano S., Ujiie A. Inhibitory effects of tranilast on proliferation, migration, and collagen synthesis of human vascular smooth muscle cells. Can J Physiol Pharmacol. 74:1996;80-84.
110. Perr H.A., Drucker D.E., Cochran D.L., Diegelmann R.F., Lindblad W.J., Graham M.F. Protamine selectively inhibits collagen synthesis by human intestinal smooth muscle cells and other mesenchymal cells. J Cell Physiol. 140:1989;463-470.
111. Nagler A., Miao H.Q., Aingorn H., Pines M., Genina O., Vlodavsky I. Inhibition of collagen synthesis, smooth muscle cell proliferation, and injury-induced intimal hyperplasia by halofuginone. Arterioscler Thromb Vasc Biol. 17:1997;194-202.
112. McCaffrey T.A., Pomerantz K.B., Sanborn T.A.et al. Specific inhibition of eIF-5A and collagen hydroxylation by a single agent. Antiproliferative and fibrosuppressive effects on smooth muscle cells from human coronary arteries. J Clin Invest. 95:1995;446-455.
113. Grainger D.J., Witchell C.M., Metcalfe J.C. Tamoxifen elevates transforming growth factor-beta and suppresses diet-induced formation of lipid lesions in mouse aorta (see comments). Nat Med. 1:1995;1067-1073.
114. Aikawa M., Rabkin E., Okada Y.et al. Lipid lowering by diet reduces matrix metalloproteinase activity and increases collagen content of rabbit atheroma: a potential mechanism of lesion stabilization (see comments). Circulation. 97:1998;2433-2444.
115. Peuhkurinen K., Risteli L., Jounela A., Risteli J. Changes in interstitial collagen metabolism during acute myocardial infarction treated with streptokinase or tissue plasminogen activator. Am Heart J. 131:1996;7-13.
116. Peuhkurinen K.J., Risteli L., Melkko J.T., Linnaluoto M., Jounela A., Risteli J. Thrombolytic therapy with streptokinase stimulates collagen breakdown. Circulation. 83:1991;1969-1975.
117. Fuster V. Mechanisms of arterial thrombosis: foundation for therapy. Am Heart J. 135:1998;S361-S366.
118. Rekhter M.D., Simari R.D., Work C.W., Nabel G.J., Nabel E.G., Gordon D. Gene transfer into normal and atherosclerotic human blood vessels. Circ Res. 82:1998;1243-1252.